1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 05 JANUARY 2015

CNS Drug News 05 JANUARY 2015

  • January 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Xadago For Parkinson's To See EC Approval And FDA Decision In H115
Industry Brief - NeuroDerm Reports Positive PK Results With Liquid Levodopa/Carbidopa
Industry Brief - SYN120 Phase IIa Trial In PD Dementia Started
Industry Trend Analysis - Namenda Hard Switch Case Will Have Wider Implications
Industry Brief - FDA Approves Actavis/Adamas' Namzaric
Industry Brief - Roche To Discontinue Gantenerumab Phase III Study In Prodromal AD
Industry Brief - Roivant Acquires SB742457 From GSK
Industry Brief - Alzheon Obtains European Patent Allowance For ALZ-801
Industry Brief - Anavex Begins Enrolment Of AD Patients In Phase IIa Trial
Industry Brief - Takeda Submits Glatiramer Acetate NDA In Japan For Relapse Prevention Of MS
Industry Brief - First Patient Treated In Mapi's Phase IIa Trial Of GA Depot For RRMS
Industry Brief - Cytokinetics/Astellas Expand Collaboration
Industry Trend Analysis - BrainStorm's Stem Cell Technology An Attractive Prospect
Industry Brief - Auspex Reports Positive Top-Line Results From SD-809 Phase III Trial For HD-Associated Chorea
Industry Brief - Lundbeck Discontinues Further Development Of Desmoteplase
Industry Brief - D-Pharm's THR-18 Phase II Study In tPA-Treated AIS Patients Achieves Primary Endpoint
Industry Brief - Vanda To Regain US/Canadian Rights To Fanapt
Industry Brief - SDP Reports Preliminary Findings From Lurasidone Phase III Study In Schizophrenia
Industry Brief - Endo/BDSI Submit NDA For Buprenorphine HCl Buccal Film
Industry Brief - Orexigen's Mysimba Receives Positive CHMP Opinion
Industry Brief - RedHill's Bekinda MAA Accepted For Review
Industry Brief - Public-Private Partnership To Research Link Between Immune System And Brain Diseases

Table Of Contents

CNS Drug News 05 JANUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Alzheimer’s disease (AD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Alzheimer’s disease ...

Amyotrophic lateral sclerosis (ALS)- Market Insights, Epidemiology and Market Forecast-2023

Amyotrophic lateral sclerosis (ALS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Amyotrophic lateral sclerosis (ALS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of ...

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

Global Multi Infarct Dementia Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

"Global Multi Infarct Dementia Market Research Report 2016" by OBRC, is an extensive study on present state of the Multi Infarct Dementia Market. The global multi-infarct dementia is estimated to reach ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.